Immunity to Malaria in Plasmodium vivax Infection: A Study in Central China

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Jangpatarapongsa, Kulachart ^a   Xia, Hui ^b   Fang, Qiang ^b   Hu, Kaiming ^b   Yuan, Yuanying ^b   Peng, Meiyu ^b   Gao, Qi ^c   Sattabongkot, Jetsumon ^d   Cui, Liwang ^e   Li, Baiqing ^b   Udomsangpetch, Rachanee ^a,f  

^a MAHIDOL UNIVERSITY   (Thailand)

^b BENGBU MEDICAL COLLEGE   (China)

^c JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^d MAHIDOL UNIVERSITY   (Thailand)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

^f NONE   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD45RO ANTIGEN; PARASITE ANTIGEN;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CROSS-SECTIONAL STUDY; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHINA; COCULTURE TECHNIQUES; CROSS-SECTIONAL STUDIES; FLOW CYTOMETRY; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALARIA, VIVAX; MIDDLE AGED; PHENOTYPE; PLASMODIUM VIVAX; T-LYMPHOCYTES;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 84866709404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045971     Document Type: Article

References (59)

1. Sachs J, Malaney P, (2002) The economic and social burden of malaria. Nature 415: 680-685.
2. Krotoski WA, Krotoski DM, Garnham PC, Bray RS, Killick-Kendrick R, et al. (1980) Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note. Br Med J 280: 153-154.
3. Panichakul T, Sattabongkot J, Chotivanich K, Sirichaisinthop J, Cui L, et al. (2007) Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. Int J Parasitol 37: 1551-1557.
4. Udomsangpetch R, Kaneko O, Chotivanich K, Sattabongkot J, (2008) Cultivation of Plasmodium vivax. Trends Parasitol 24: 85-88.
5. Sattabongkot J, Tsuboi T, Zollner GE, Sirichaisinthop J, Cui L, (2004) Plasmodium vivax transmission: chances for control? Trends Parasitol 20: 192-198.
6. Achidi EA, Perlmann H, Salimonu LS, Perlmann P, Walker O, et al. (1995) A longitudinal study of seroreactivities to Plasmodium falciparum antigens in Nigerian infants during their first year of life. Acta Trop 59: 173-183.
7. Hviid L, (1998) Clinical disease, immunity and protection against Plasmodium falciparum malaria in populations living in endemic areas. Expert Rev Mol Med 1998: 1-10.
8. Hviid L, (2005) Naturally acquired immunity to Plasmodium falciparum malaria in Africa. Acta Trop 95: 270-275.
9. Iriemenam NC, Okafor CM, Balogun HA, Ayede I, Omosun Y, et al. (2009) Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria. Afr Health Sci 9: 66-74.
10. Osier FH, Polley SD, Mwangi T, Lowe B, Conway DJ, et al. (2007) Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol 29: 387-394.
11. Riley EM, Allen SJ, Wheeler JG, Blackman MJ, Bennett S, et al. (1992) Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol 14: 321-337.
12. Doolan DL, Dobano C, Baird JK, (2009) Acquired immunity to malaria. Clin Microbiol Rev 22: 13-36.
13. Chuangchaiya S, Jangpatarapongsa K, Chootong P, Sirichaisinthop J, Sattabongkot J, et al. (2010) Immune response to Plasmodium vivax has a potential to reduce malaria severity. Clin Exp Immunol 160: 233-239.
14. Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, et al. (2011) Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis 52: 612-620.
15. Kochar DK, Tanwar GS, Khatri PC, Kochar SK, Sengar GS, et al. (2010) Clinical features of children hospitalized with malaria-a study from Bikaner, northwest India. Am J Trop Med Hyg 83: 981-989.
16. Lin E, Kiniboro B, Gray L, Dobbie S, Robinson L, et al. (2010) Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. PLoS One 5: e9047.
17. Lin JT, Bethell D, Tyner SD, Lon C, Shah NK, et al. (2011) Plasmodium falciparum gametocyte carriage is associated with subsequent Plasmodium vivax relapse after treatment. PLoS One 6: e18716.
18. Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, et al. (2007) The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76: 997-1008.
19. Snounou G, White NJ, (2004) The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol 20: 333-339.
20. Jangpatarapongsa K, Chootong P, Sattabongkot J, Chotivanich K, Sirichaisinthop J, et al. (2008) Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur J Immunol 38: 2697-2705.
21. Jangpatarapongsa K, Sirichaisinthop J, Sattabongkot J, Cui L, Montgomery SM, et al. (2006) Memory T cells protect against Plasmodium vivax infection. Microbes Infect 8: 680-686.
22. Woodberry T, Minigo G, Piera KA, Hanley JC, de Silva HD, et al. (2008) Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses. J Infect Dis 198: 134-142.
23. Diggs CL, Sadun EH, (1965) Serological Cross Reactivity between Plasmodium vivax and Plasmodium falciparum as Determined by a Modified Fluorescent Antibody Test. Exp Parasitol 16: 217-223.
24. Kassa D, Petros B, Mesele T, Hailu E, Wolday D, (2006) Characterization of peripheral blood lymphocyte subsets in patients with acute Plasmodium falciparum and P. vivax malaria infections at Wonji Sugar Estate, Ethiopia. Clin Vaccine Immunol 13: 376-379.
25. Zhang W, Wang L, Fang L, Ma J, Xu Y, et al. (2008) Spatial analysis of malaria in Anhui province, China. Malar J 7: 206.
26. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, (1993) Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58: 283-292.
27. Qingjun L, Jihui D, Laiyi T, Xiangjun Z, Jun L, et al. (1998) The effect of drug packaging on patients' compliance with treatment for Plasmodium vivax malaria in China. Bull World Health Organ 76 (Suppl 1): 21-27.
28. Trager W, Jensen JB, (1997) Continuous culture of Plasmodium falciparum: its impact on malaria research. Int J Parasitol 27: 989-1006.
29. Bergmann ES, Ballou RW, Krzych U, (1997) Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites. Cell Immunol 180: 143-152.
30. Palmer DR, Krzych U, (2002) Cellular and molecular requirements for the recall of IL-4-producing memory CD4(+)CD45RO(+)CD27(-) T cells during protection induced by attenuated Plasmodium falciparum sporozoites. Eur J Immunol 32: 652-661.
31. Wipasa J, Okell L, Sakkhachornphop S, Suphavilai C, Chawansuntati K, et al. (2011) Short-lived IFN-gamma effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS Pathog 7: e1001281.
32. Salwati E, Minigo G, Woodberry T, Piera KA, de Silva HD, et al. (2011) Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria. J Infect Dis 203: 1192-1199.
33. Tsuji MA, (2010) retrospective evaluation of the role of T cells in the development of malaria vaccine. Exp Parasitol 126: 421-425.
34. Artavanis-Tsakonas K, Riley EM, (2002) Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol 169: 2956-2963.
35. Bordessoule D, Gaulard P, Mason DY, (1990) Preferential localisation of human lymphocytes bearing gamma delta T cell receptors to the red pulp of the spleen. J Clin Pathol 43: 461-464.
36. Perera MK, Carter R, Goonewardene R, Mendis KN, (1994) Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms. J Exp Med 179: 311-315.
37. Seixas EM, Langhorne J, (1999) gammadelta T cells contribute to control of chronic parasitemia in Plasmodium chabaudi infections in mice. J Immunol 162: 2837-2841.
38. Behr C, Dubois P, (1992) Preferential expansion of V gamma 9 V delta 2 T cells following stimulation of peripheral blood lymphocytes with extracts of Plasmodium falciparum. Int Immunol 4: 361-366.
39. Farouk SE, Mincheva-Nilsson L, Krensky AM, Dieli F, Troye-Blomberg M, (2004) Gamma delta T cells inhibit in vitro growth of the asexual blood stages of Plasmodium falciparum by a granule exocytosis-dependent cytotoxic pathway that requires granulysin. Eur J Immunol 34: 2248-2256.
40. Goodier M, Fey P, Eichmann K, Langhorne J, (1992) Human peripheral blood gamma delta T cells respond to antigens of Plasmodium falciparum. Int Immunol 4: 33-41.
41. Troye-Blomberg M, Worku S, Tangteerawatana P, Jamshaid R, Soderstrom K, et al. (1999) Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules. Scand J Immunol 50: 642-650.
42. Asito AS, Moormann AM, Kiprotich C, Ng'ang'a ZW, Ploutz-Snyder R, et al. (2008) Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar J 7: 238.
43. Lee HK, Lim J, Kim M, Lee S, Oh EJ, et al. (2001) Immunological alterations associated with Plasmodium vivax malaria in South Korea. Ann Trop Med Parasitol 95: 31-39.
44. Lim HW, Hillsamer P, Banham AH, Kim CH, (2005) Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 175: 4180-4183.
45. Nogaro SI, Hafalla JC, Walther B, Remarque EJ, Tetteh KK, et al. (2011) The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission. PLoS One 6: e25582.
46. Weiss GE, Clark EH, Li S, Traore B, Kayentao K, et al. (2011) A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali. PLoS One 6: e15983.
47. Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, et al. (2009) Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 183: 2176-2182.
48. Ribeiro CD, (1988) Polyclonal B-cell activation (PBA) what have we hearned from the study of malaria? Mem Inst Oswaldo Cruz 83: 633-648.
49. Vieira PL, Christensen JR, Minaee S, O'Neill EJ, Barrat FJ, et al. (2004) IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172: 5986-5993.
50. Shevach EM, (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2: 389-400.
51. Bueno LL, Morais CG, Araujo FF, Gomes JA, Correa-Oliveira R, et al. (2010) Plasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites. PLoS One 5: e9623.
52. Goncalves RM, Salmazi KC, Santos BA, Bastos MS, Rocha SC, et al. (2010) CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses? Infect Immun 78: 4763-4772.
53. Walther M, Tongren JE, Andrews L, Korbel D, King E, et al. (2005) Upregulation of TGF-b, Foxp3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23: 287-296.
54. Srisurapanon S, Wiwattanakul S, Apibal S, Suwannuruk R, Sujimanaskul S, et al. (2003) Lymphocyte subpopulations in malaria infected individuals living in an endemic area. Southeast Asian J Trop Med Public Health 34: 310-315.
55. Mavoungou E, Luty AJ, Kremsner PG, (2003) Natural killer (NK) cell-mediated cytolysis of Plasmodium falciparum-infected human red blood cells in vitro. Eur Cytokine Netw 14: 134-142.
56. Hviid L, Kemp K, (2000) What is the cause of lymphopenia in malaria? Infect Immun 68: 6087-6089.
57. Richards MW, Behrens RH, Doherty JF, (1998) Short report: hematologic changes in acute, imported Plasmodium falciparum malaria. Am J Trop Med Hyg 59: 859.
58. Landewe RB, Miltenburg AM, Verdonk MJ, Verweij CL, Breedveld FC, et al. (1995) Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness. Clin Exp Immunol 102: 144-151.
59. Schultz KR, Bader S, Paquet J, Li W, (1995) Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease. Blood 86: 4344-4352.